Behçet's disease‐like clinical manifestations of chronic lymphocytic leukemia during good response to ibrutinib

Ibrutinib has been reported to have various effects on the immune system, including a shift of T cells to Th1 dominance via the suppression of IL2-inducible T-cell kinase. CONFLICT OF INTEREST STATEMENT The authors declare that we have no conflict of interest. DATA AVAILABILITY STATEMENT The dataset...

Full description

Saved in:
Bibliographic Details
Published in:EJHaem 2023-08, Vol.4 (3), p.859-860
Main Authors: Obama, Kosuke, Yamamoto, Hana, Inoue, Hirosaka
Format: Article
Language:English
Subjects:
Abdomen
Behcet's syndrome
Behçet's disease
Blood
CD11c
Chronic lymphocytic leukemia
Conflicts of interest
Flow cytometry
Haematology Images
ibrutinib
Immune system
Leukemia
Leukocytes
Lymphatic leukemia
Lymphocytes
Lymphocytes T
Vein & artery diseases
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Ibrutinib has been reported to have various effects on the immune system, including a shift of T cells to Th1 dominance via the suppression of IL2-inducible T-cell kinase. CONFLICT OF INTEREST STATEMENT The authors declare that we have no conflict of interest. DATA AVAILABILITY STATEMENT The dataset generated during the current study are not publicly available but are available from the corresponding author on reasonable request.
ISSN:2688-6146
2688-6146
DOI:10.1002/jha2.752